Q2 2025 Prestige Consumer Healthcare Inc Earnings Call Transcript
Key Points
- Prestige Consumer Healthcare Inc (PBH) exceeded expectations for Q2 fiscal 2025, with stable earnings and cash flow.
- The company reported strong free cash flow of $68 million, growing double digits compared to the prior year.
- Debt reduction efforts resulted in a $40 million decrease in debt, lowering the leverage ratio to 2.7x.
- The Canadian portfolio showed strong growth, with a sales CAGR of approximately 4% since fiscal 2020.
- The International segment, particularly the Hydralyte brand, demonstrated strong growth, contributing positively to overall performance.
- Sales declined slightly to $284 million compared to the prior year, primarily due to supply chain limitations affecting the Clear Eyes brand.
- The eye and ear care category experienced declines, impacted by Clear Eyes supply constraints and timing of cough and cold ordering patterns.
- Gross margin for the first six months was slightly down at 55.1% due to expedited freight costs for Clear Eyes.
- Adjusted EPS decreased to $1.98 from $2.13 in the prior year, affected by lower Q1 revenues and increased air freight costs.
- The company faces ongoing supply chain challenges, particularly with the Clear Eyes brand, impacting inventory levels and sales.
Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's second-quarter 2025 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to introduce your host for today's conference call, Phil Terpolilli, Vice President, Investor Relations. Please go ahead.
Thanks, operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President and CEO; and Christine Sacco, our CFO.
On today's call, we'll review the second quarter fiscal 2025 results, discuss our full year outlook and then take questions from analysts. A slide presentation that accompanies today's call can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the Investors link and then on today's webcast and presentation.
Remember, some of the information contained in the presentation today includes non-GAAP financial measures.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
